<DOC>
	<DOCNO>NCT01824771</DOCNO>
	<brief_summary>Continuous Veno-Venous Hemofiltration ( CVVH ) eliminate metabolic product effectively replace renal function partly . It widely use intensive care unit ( ICUs ) , especially patient acute kidney injury/failure unstable hemodynamic status . Lactate molecule small glucose , pas filtration membrane freely CVVH . Therefore , blood lactate concentration would longer reflect tissue oxygenation status patient unstable hemodynamic status . However , prospective study evaluate effect CVVH lactate removal critically ill patient . The influence different dose CVVH lactate elimination clear patient different level serum lactate . Our study aim find dose CVVH effect lactate clearance , re-estimate prognostic value lactate critically ill patient CVVH .</brief_summary>
	<brief_title>Effects Continuous Veno-venous Haemofiltration Plasma Lactate Critically Ill Patients</brief_title>
	<detailed_description />
	<mesh_term>Acute Kidney Injury</mesh_term>
	<criteria>1 . The critical ill patient acute kidney injury 2 . Patients require continuous venovenous hemofiltration 3 . APACHE II score 12 4 . Arterial lactate higher 0.5mmol/L low 15mmol/L ( due sensitivity optimal measuring range equipment ) 5 . Continuous venovenous hemofiltration least 12 hrs 6 . Hemofilter age &lt; 24 hr 1 . APACHE II score low 12 2. patient ' age 75Y low 18Y</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Continuous veno-venoous haemofiltration</keyword>
	<keyword>Plasma lactate</keyword>
	<keyword>Critical illness</keyword>
	<keyword>Acute kidney injurytissue perfusion</keyword>
	<keyword>Multiple organ dysfunction syndrome</keyword>
</DOC>